Found 338 chains in Genus chains table. Displaying 1 - 50. Applied filters: Proteins

Search results query: hla class ii histocompatibility antigen, dr alpha chain

Total Genus Sequence Length pdb Title
31 188 8vrwB Cryo-em structure of human invariant chain in complex with hla-dr15
15 56 8vrwC Cryo-em structure of human invariant chain in complex with hla-dr15
28 180 8vrwA Cryo-em structure of human invariant chain in complex with hla-dr15
34 178 8tbpA Hla-drb1*15:01 in complex with smith antigen
41 189 8tbpB Hla-drb1*15:01 in complex with smith antigen
41 189 7o00BBB Crystal structure of hla-dr4 in complex with a hsp70 peptide
45 189 7nzhBBB Crystal structure of hla-dr4 in complex with a citrullinated cilp peptide
38 189 7nzfBBB Crystal structure of hla-dr4 in complex with a mutated human collagen type ii peptide
35 180 7nzfAAA Crystal structure of hla-dr4 in complex with a mutated human collagen type ii peptide
32 180 7nzhAAA Crystal structure of hla-dr4 in complex with a citrullinated cilp peptide
31 177 7o00AAA Crystal structure of hla-dr4 in complex with a hsp70 peptide
41 189 8cmfB Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 nsp3 epitope (orf1ab)1350-1364
40 194 8cmbB Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 spike peptide s486-505
44 192 8cmgB Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 nsp14 peptide (orf1ab)6420-6434
0 14 8cmbC Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 spike peptide s486-505
35 180 8cmbA Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 spike peptide s486-505
36 182 8cmgA Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 nsp14 peptide (orf1ab)6420-6434
35 180 8cmhA Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 omicron (ba.1) spike peptide s486-505
0 14 8cmhC Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 omicron (ba.1) spike peptide s486-505
40 194 8cmhB Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 omicron (ba.1) spike peptide s486-505
33 183 8cmiA Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 omicron (ba.1) spike peptide s761-775
45 191 8cmeB Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 membrane peptide m176-190
34 182 8cmeA Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 membrane peptide m176-190
0 14 8cmcC Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 spike peptide s511-530
34 181 8cmfA Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 nsp3 epitope (orf1ab)1350-1364
0 15 8cmeC Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 membrane peptide m176-190
40 190 8cmdB Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 spike peptide s761-775
42 191 8cmiB Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 omicron (ba.1) spike peptide s761-775
47 192 8cmcB Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 spike peptide s511-530
33 183 8cmdA Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 spike peptide s761-775
0 15 8cmgC Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 nsp14 peptide (orf1ab)6420-6434
35 182 8cmcA Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 spike peptide s511-530
40 222 8euqC Crystal structure of hla-dra*01:01/hla-drb1*04:01 in complex with c44h10 fab
42 216 8euqB Crystal structure of hla-dra*01:01/hla-drb1*04:01 in complex with c44h10 fab
29 185 8euqA Crystal structure of hla-dra*01:01/hla-drb1*04:01 in complex with c44h10 fab
43 212 8euqD Crystal structure of hla-dra*01:01/hla-drb1*04:01 in complex with c44h10 fab
33 178 7z0qC Mhc-ii dynamics are maintained in hla-dr allotypes to ensure catalyzed peptide exchange
35 188 7z0qD Mhc-ii dynamics are maintained in hla-dr allotypes to ensure catalyzed peptide exchange
47 193 7yx9B Mhc-ii dynamics are maintained in hla-dr allotypes to ensure catalyzed peptide exchange
49 192 7yxbB Mhc-ii dynamics are maintained in hla-dr allotypes to ensure catalyzed peptide exchange
35 179 7yx9A Mhc-ii dynamics are maintained in hla-dr allotypes to ensure catalyzed peptide exchange
36 181 7yxbA Mhc-ii dynamics are maintained in hla-dr allotypes to ensure catalyzed peptide exchange
42 190 7nzeBBB Crystal structure of hla-dr4 in complex with a human collagen type ii peptide
35 179 7nzeAAA Crystal structure of hla-dr4 in complex with a human collagen type ii peptide
35 179 7n19A Dr3 in complex with aspergillus nidulans nad-dependent histone deacetylase hst4 peptide
45 187 7n19B Dr3 in complex with aspergillus nidulans nad-dependent histone deacetylase hst4 peptide
53 242 6v0yE Immune receptor complex
36 205 6v0yD Immune receptor complex
28 177 6v0yA Immune receptor complex
31 177 6v19A Immune receptor complex
How to cite